Table 1.

Comparison of the human-based producer cell line Phoenix-GALV with the murine-based producer cell line PG13: transduction and engraftment of baboon marrow cells

AnimalProducer
cell line
% FACS+
on day 3
% EGFP/EYFP+
colonies
Cells
infused
Days to
ANC > 500
Follow-up
(weeks)
F99070 Phoenix-GALV 23.3 15.7 7.6 × 106/kg 16 68 
 PG13 9.2 7.8    
00021 Phoenix-GALV 20.8 24.8 12.6 × 106/kg 11 65 
 PG13 5.2 8.1    
A00066 Phoenix-GALV 16.2 20.6 15.2 × 106/kg 18 12* 
 PG13 6.4 4.4    
AnimalProducer
cell line
% FACS+
on day 3
% EGFP/EYFP+
colonies
Cells
infused
Days to
ANC > 500
Follow-up
(weeks)
F99070 Phoenix-GALV 23.3 15.7 7.6 × 106/kg 16 68 
 PG13 9.2 7.8    
00021 Phoenix-GALV 20.8 24.8 12.6 × 106/kg 11 65 
 PG13 5.2 8.1    
A00066 Phoenix-GALV 16.2 20.6 15.2 × 106/kg 18 12* 
 PG13 6.4 4.4    

All animals studied were transplanted as outlined in “Materials and methods” with oncoretroviral vectors pseudotyped by either Phoenix-GALV or PG13 as noted. Displayed are, for both vectors in each of the 3 animals, the percentage of fluorescence-positive cells in liquid culture 3 days after transduction and the percentage of fluorescence-positive colonies plated immediately after transduction. Growth factors used for this set of animals were stem cell factor, granulocyte colony-stimulating factor, and megakaryocyte growth and development factor at 100 ng/mL each.

Phoenix-GALV indicates Phoenix-GALV/MNDEYFPSN; PG13, PG13/MNDEGFPSN; EGFP, enhanced green fluorescent protein; EYFP, enhanced yellow fluorescent protein; and ANC, absolute neutrophil count.

*

Follow-up on this animal was discontinued and it was transferred to a different study.

or Create an Account

Close Modal
Close Modal